Want to join the conversation?
Janssen Research & Development, LLC, a part of $JNJ said that it has announced research alliances through its Disease Interception Accelerator (DIA). The Boston University School of Medicine aims at identifying disease pathways related to COPD, while the Agency for Science, Technology & Research focuses on identifying biomarkers in GDM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.